171 related articles for article (PubMed ID: 35840721)
1. Adenoid ameloblastoma harbors beta-catenin mutations.
Bastos VC; Coura BP; Guimarães LM; Fernandes BG; Chan AC; Vargas PA; Bastos-Rodrigues L; De Marco LA; Hellstein J; Thavaraj S; Wright JM; Odell EW; Gomez RS; Gomes CC
Mod Pathol; 2022 Nov; 35(11):1562-1569. PubMed ID: 35840721
[TBL] [Abstract][Full Text] [Related]
2. Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors.
Coura BP; Dos Santos JN; Fonseca FP; Bernardes VF; de Aquino SN; Jorge Júnior J; Vargas PA; Romañach MJ; de Andrade BAB; Gomez RS; Gomes CC
J Oral Pathol Med; 2021 Nov; 50(10):1067-1071. PubMed ID: 34549835
[TBL] [Abstract][Full Text] [Related]
3. Adenoid Ameloblastoma Shares Clinical, Histologic, and Molecular Features With Dentinogenic Ghost Cell Tumor: The Histologic Spectrum of WNT Pathway-Altered Benign Odontogenic Tumors.
Oh KY; Hong SD; Yoon HJ
Mod Pathol; 2023 Mar; 36(3):100051. PubMed ID: 36788106
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of odontogenic cysts and tumours.
Gomes IP; Bastos VC; Guimarães LM; Gomes CC
J Oral Pathol Med; 2023 Apr; 52(4):351-356. PubMed ID: 36629457
[TBL] [Abstract][Full Text] [Related]
5. Adenoid 'ameloblastoma': Clinicopathological description of 4 additional BRAF-negative cases.
Khalaj F; Cinel L; Aminishakib P; Mosavat F; Soluk-Tekkesin M
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101585. PubMed ID: 37543210
[TBL] [Abstract][Full Text] [Related]
6. BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type.
Oh KY; Kim JH; Cho SD; Yoon HJ; Lee JI; Hong SD
Genes Chromosomes Cancer; 2022 Aug; 61(8):481-490. PubMed ID: 35353428
[TBL] [Abstract][Full Text] [Related]
7. Adenoid Ameloblastoma Versus Dentinogenic Ghost Cell Tumor.
Bastos VC; Gomes CC; Gomez RS
Head Neck Pathol; 2023 Mar; 17(1):275-276. PubMed ID: 36169792
[TBL] [Abstract][Full Text] [Related]
8. Adenoid Ameloblastoma with BRAF p.V600E Mutation Revealing Ameloblastomatous Origin: A First Case Report.
Noda Y; Sawada S; Sakagami T; Kojima Y; Higasa K; Tsuta K
Head Neck Pathol; 2023 Sep; 17(3):788-792. PubMed ID: 37093491
[TBL] [Abstract][Full Text] [Related]
9. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors.
Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I
Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730
[TBL] [Abstract][Full Text] [Related]
10. Aberrant beta-catenin expression and adenomatous polyposis coli gene mutation in ameloblastoma and odontogenic carcinoma.
Siriwardena BS; Kudo Y; Ogawa I; Tilakaratne WM; Takata T
Oral Oncol; 2009 Feb; 45(2):103-8. PubMed ID: 18486530
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Enigma of Adenoid Ameloblastoma: Literature Review Based Evidence to Consider It as a New Sub Type of Ameloblastoma.
Jayasooriya PR; Abeyasinghe WAMUL; Liyanage RLPR; Uthpali GN; Tilakaratne WM
Head Neck Pathol; 2022 Jun; 16(2):344-352. PubMed ID: 34282559
[TBL] [Abstract][Full Text] [Related]
12. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.
Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS
Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168
[TBL] [Abstract][Full Text] [Related]
13. Genetic basis of calcifying cystic odontogenic tumors.
Yukimori A; Oikawa Y; Morita KI; Nguyen CTK; Harada H; Yamaguchi S; Kayamori K; Yamaguchi A; Ikeda T; Sakamoto K
PLoS One; 2017; 12(6):e0180224. PubMed ID: 28658279
[TBL] [Abstract][Full Text] [Related]
14. Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
Brown NA; Rolland D; McHugh JB; Weigelin HC; Zhao L; Lim MS; Elenitoba-Johnson KS; Betz BL
Clin Cancer Res; 2014 Nov; 20(21):5517-26. PubMed ID: 24993163
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma.
Mendez LD; Wolsefer NS; Asa SL; Wasman J; Yoest JM; Stojanov IJ
Mod Pathol; 2022 Nov; 35(11):1570-1577. PubMed ID: 35676332
[TBL] [Abstract][Full Text] [Related]
16. [Implication of BRAF V600E and CTNNB1 gene mutations in the pathological classification of craniopharyngioma].
Xu SS; Wang LM; Zhao LH; He ZL; Gong LP; Lu DH; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2019 Sep; 48(9):682-687. PubMed ID: 31495087
[No Abstract] [Full Text] [Related]
17. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts.
Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674
[TBL] [Abstract][Full Text] [Related]
18. Adenoid Ameloblastoma vs Dentinogenic Ghost Cell Tumor: Are They Related Entities?
Bastos VC; Guimarães LM; Gomes CC; Gomez RS
Mod Pathol; 2023 Apr; 36(4):100132. PubMed ID: 36924756
[No Abstract] [Full Text] [Related]
19. A Systematic Review of Adenoid Ameloblastoma: A Newly Recognized Entity.
de Farias Morais HG; Gonçalo RIC; de Oliveira Costa CS; de Figueiredo Pires H; Mafra RP; de Morais EF; da Costa Miguel MC; de Almeida Freitas R
Head Neck Pathol; 2023 Sep; 17(3):688-696. PubMed ID: 37540485
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnostics in odontogenic tumors.
Buettner R; Gültekin SE
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):81-85. PubMed ID: 36378285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
